Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Backer

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 5, 2002
Environmental factors as a cause for the increase in allergic diseaseH Nolte, V Backer, C Porsbjerg
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2016
A "Dock and Lock" Approach to Preparation of Targeted LiposomesMarina V Backer, Joseph M Backer
Scandinavian Journal of Medicine & Science in Sports|December 21, 2007
Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?V Backer, T Lund, L Pedersen
Ugeskrift for Laeger|May 4, 1981
[Bioavailability of 3 peroral potassium preparations]S Jørgensen, V Backer, E Langhoff
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
A "dock and lock" approach to preparation of targeted liposomesMarina V Backer, Joseph M Backer
Ugeskrift for Laeger|August 18, 1986
[Beclomethasone or budesonide?]N V Backer, F V Rasmussen
Scandinavian Journal of Infectious Diseases|January 1, 1995
Persistent reduction in lung function after Pneumocystis carinii pneumonia in AIDS patientsS Nelsing, B N Jensen, V Backer
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1992
Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow upC S Ulrik, V Backer, A Dirksen
Allergy|September 19, 2012
Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitisK Aasbjerg, C Torp-Pedersen, V Backer
Nordisk Medicin|January 1, 1994
[Cytomegalovirus infection--a review]K K Hansen, V Backer, P Skinhøj
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 5, 2002
Environmental factors as a cause for the increase in allergic diseaseH Nolte, V Backer, C Porsbjerg
Methods in Molecular Biology (Clifton, N.J.)|November 13, 2016
A "Dock and Lock" Approach to Preparation of Targeted LiposomesMarina V Backer, Joseph M Backer
Scandinavian Journal of Medicine & Science in Sports|December 21, 2007
Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?V Backer, T Lund, L Pedersen
Ugeskrift for Laeger|May 4, 1981
[Bioavailability of 3 peroral potassium preparations]S Jørgensen, V Backer, E Langhoff
Methods in Molecular Biology (Clifton, N.J.)|January 15, 2010
A "dock and lock" approach to preparation of targeted liposomesMarina V Backer, Joseph M Backer
Ugeskrift for Laeger|August 18, 1986
[Beclomethasone or budesonide?]N V Backer, F V Rasmussen
Scandinavian Journal of Infectious Diseases|January 1, 1995
Persistent reduction in lung function after Pneumocystis carinii pneumonia in AIDS patientsS Nelsing, B N Jensen, V Backer
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 1, 1992
Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow upC S Ulrik, V Backer, A Dirksen
Allergy|September 19, 2012
Specific immunotherapy can greatly reduce the need for systemic steroids in allergic rhinitisK Aasbjerg, C Torp-Pedersen, V Backer
Nordisk Medicin|January 1, 1994
[Cytomegalovirus infection--a review]K K Hansen, V Backer, P Skinhøj
Pageof 19